106 related articles for article (PubMed ID: 36802454)
21. CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1.
Wang Q; Xie Z; Li C; Xu C; Ding C; Ju S; Chen J; Cui Z; Chen C; Gu B; Wei T; Zhao J
J Mol Histol; 2022 Aug; 53(4):657-667. PubMed ID: 35716330
[TBL] [Abstract][Full Text] [Related]
22. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
Zhao L; Bi M; Zhang H; Shi M
Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
[No Abstract] [Full Text] [Related]
24. Silencing of
Zhang P; Li Z; Yang G
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
[TBL] [Abstract][Full Text] [Related]
25. Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo.
Chen J; Huang X; Tao C; Wang L; Chen Z; Li X; Zeng Q; Ma M; Zhang R; Wu Z
Cancer Chemother Pharmacol; 2020 Jul; 86(1):151-161. PubMed ID: 32607786
[TBL] [Abstract][Full Text] [Related]
26. PHB2 promotes tumorigenesis
Wu B; Chang N; Xi H; Xiong J; Zhou Y; Wu Y; Wu S; Wang N; Yi H; Song Y; Chen L; Zhang J
Theranostics; 2021; 11(7):3150-3166. PubMed ID: 33537079
[No Abstract] [Full Text] [Related]
27. miR-140-3p inhibits progression of non-small cell lung cancer by targeting Janus kinase 1.
Hu C; Zou Y; Jing LL
J Biosci; 2020; 45():. PubMed ID: 32345774
[TBL] [Abstract][Full Text] [Related]
28. lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis.
Qi L; Liu F; Zhang F; Zhang S; Lv L; Bi Y; Yu Y
Biomed Pharmacother; 2018 Jul; 103():1507-1515. PubMed ID: 29864936
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
[TBL] [Abstract][Full Text] [Related]
31. Ectopic circSTK39 Expression Ameliorates Hydrogen Peroxide-Induced Human Lens Epithelial Cell Apoptosis and Oxidative Stress through the miR-125a-5p/ERCC6 Pathway.
Guo M; Su F; Chen Y; Su B
Curr Eye Res; 2023 Mar; 48(3):278-288. PubMed ID: 36322706
[TBL] [Abstract][Full Text] [Related]
32. HOXC-AS2 mediates the proliferation, apoptosis, and migration of non-small cell lung cancer by combining with HOXC13 gene.
Liu B; Li J; Li JM; Liu GY; Wang YS
Cell Cycle; 2021 Jan; 20(2):236-246. PubMed ID: 33427025
[TBL] [Abstract][Full Text] [Related]
33. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer.
Liu XH; Liu ZL; Sun M; Liu J; Wang ZX; De W
BMC Cancer; 2013 Oct; 13():464. PubMed ID: 24103700
[TBL] [Abstract][Full Text] [Related]
34. Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer.
Zhan Y; Chen R; Wang T; Shan S; Zhu H
Exp Lung Res; 2021 Apr; 47(3):111-120. PubMed ID: 33336613
[TBL] [Abstract][Full Text] [Related]
35. microRNA-1321 and microRNA-7515 contribute to the progression of non-small cell lung cancer by targeting CDC20.
Hu H; Tou FF; Mao WM; Xu YL; Jin H; Kuang YK; Han CB; Guo CY
Kaohsiung J Med Sci; 2022 May; 38(5):425-436. PubMed ID: 35050556
[TBL] [Abstract][Full Text] [Related]
36. Circ_0074027 contributes to non-small cell lung cancer progression through positively modulating RHOA via sequestering miR-2467-3p.
Duan Z; Wei S; Liu Y
J Bioenerg Biomembr; 2021 Apr; 53(2):223-233. PubMed ID: 33687619
[TBL] [Abstract][Full Text] [Related]
37. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
38. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
Song J; Su ZZ; Shen QM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
[TBL] [Abstract][Full Text] [Related]
39. Circ_0006006 facilitates non-small cell lung cancer progression by modulating miR-924/SRSF7 axis.
Xu Q; Shi J; Zhang L; Sheng Y; Zhang Y; Chu D; Xu A
J Gene Med; 2022 May; 24(5):e3411. PubMed ID: 35037349
[TBL] [Abstract][Full Text] [Related]
40. MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.
Wei K; Pan C; Yao G; Liu B; Ma T; Xia Y; Jiang W; Chen L; Chen Y
Cell Physiol Biochem; 2017; 44(4):1545-1558. PubMed ID: 29197876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
